G 
6,650
-1.63%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in KRW, from our data supplier.
Revenue
₩5.84bn
FY2020FY2025
Net income
−₩35.13bn
FY2020FY2025
Free cash flow
−₩39.84bn
FY2020FY2025
Shareholders' equity
₩116.49bn
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | ₩5.84bn | ₩24.3m | ₩5.32bn | ₩3.50bn | ₩5.60bn | ₩11.02bn |
| Gross profit | ₩5.84bn | ₩24.3m | ₩5.32bn | ₩3.50bn | ₩5.60bn | — |
| Research and development | ₩33.03bn | ₩34.31bn | ₩40.15bn | ₩599.8m | ₩23.34bn | ₩24.86bn |
| Operating income | −₩40.51bn | −₩48.26bn | −₩53.30bn | −₩67.95bn | −₩32.09bn | −₩22.87bn |
| Net income | −₩35.13bn | −₩58.78bn | −₩55.50bn | −₩79.83bn | −₩150.74bn | −₩75.93bn |
| Diluted earnings per share | -550.15 | -1,123.29 | -1,046.91 | -1,510.56 | -3,193.81 | -1,436.77 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | ₩127.46bn | ₩45.77bn | ₩81.34bn | ₩106.33bn | ₩179.87bn | ₩59.43bn |
| Cash and short-term investments | — | ₩15.41bn | ₩44.73bn | ₩64.29bn | — | ₩15.24bn |
| Total liabilities | ₩10.96bn | ₩16.72bn | ₩9.64bn | ₩10.69bn | ₩9.44bn | ₩171.79bn |
| Debt | — | ₩11.97bn | ₩3.72bn | ₩4.27bn | ₩4.36bn | ₩168.75bn |
| Shareholders' equity | ₩116.49bn | ₩29.05bn | ₩71.70bn | ₩95.65bn | ₩170.43bn | −₩112.36bn |
| Shares outstanding | 64m | 52m | 53m | 53m | 47m | 53m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | −₩32.30bn | −₩43.43bn | −₩41.17bn | −₩62.55bn | −₩26.58bn | −₩15.18bn |
| Capital spending | −₩7.54bn | −₩24.7m | −₩579.2m | −₩2.97bn | −₩4.92bn | −₩3.21bn |
| Free cash flow | −₩39.84bn | −₩43.45bn | −₩41.75bn | −₩65.52bn | −₩31.50bn | −₩18.39bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | ₩5.50bn | — | ₩125.8m | ₩212.3m | — | — |
| Gross profit | — | — | ₩5.50bn | — | ₩125.8m | ₩212.3m | — | — |
| Operating income | −₩14.37bn | −₩12.04bn | −₩7.12bn | −₩10.74bn | −₩10.81bn | −₩12.49bn | −₩20.02bn | −₩13.82bn |
| Net income | −₩14.25bn | −₩12.33bn | −₩3.10bn | −₩9.45bn | −₩9.76bn | −₩12.82bn | −₩19.96bn | −₩14.23bn |
| Diluted earnings per share | -221.91 | -191.97 | -48.58 | -148.46 | -157.99 | -208.03 | -381.32 | -267.90 |
| Cash from operations | −₩12.96bn | −₩10.87bn | −₩2.98bn | −₩9.21bn | −₩11.08bn | −₩9.04bn | −₩43.43bn | −₩30.54bn |
| Capital spending | −₩76.0m | −₩6.38bn | −₩1.51bn | −₩441.0m | −₩4.79bn | −₩795.0m | −₩24.0m | −₩16.0m |
| Free cash flow | −₩13.03bn | −₩17.25bn | −₩4.49bn | −₩9.65bn | −₩15.87bn | −₩9.83bn | −₩43.45bn | −₩30.56bn |
| Total assets | ₩105.53bn | ₩116.12bn | ₩127.46bn | ₩129.15bn | ₩136.85bn | ₩144.53bn | ₩45.77bn | ₩64.82bn |
| Cash and short-term investments | — | — | — | — | — | ₩114.67bn | ₩15.41bn | ₩28.40bn |
| Debt | — | — | — | — | — | ₩2.45bn | ₩11.10bn | ₩11.02bn |
| Shareholders' equity | ₩96.64bn | ₩107.80bn | ₩116.49bn | ₩117.09bn | ₩119.39bn | ₩127.22bn | ₩29.05bn | ₩47.57bn |
Financial ratios
Data as of 30 Aug 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating margin | -693.8% | -198751.9% | -1002.2% | -1941.5% | -573.0% |
| Net margin | -601.8% | -242096.1% | -1043.4% | -2280.9% | -2691.8% |
| Return on equity | -30.2% | -202.4% | -77.4% | -83.5% | -88.4% |
| Return on assets | -27.6% | -128.4% | -68.2% | -75.1% | -83.8% |
| Revenue growth | 23943.4% | -99.5% | 52.0% | -37.5% | — |
| Earnings growth | -40.2% | 5.9% | -30.5% | -47.0% | — |
| Current ratio | 5.69x | 4.20x | 8.32x | 10.99x | 25.60x |
| Debt to equity | — | 0.29x | 0.00x | 0.00x | — |
| Equity ratio | 91.4% | 63.5% | 88.2% | 89.9% | 94.8% |
| Interest coverage | -25.92x | -48.82x | -147.07x | -174.78x | -113.96x |
| R&D as a share of sales | 565.8% | 141316.8% | 754.8% | 17.1% | 416.8% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 18.6% | -11.9% | — |
| Operating income | -15.8% | 12.1% | — |
| Net income | -23.9% | -14.3% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 100.0% | 100.0% | — | — |
| Operating margin | -1514.2% | -1430.5% | -846.7% | — |
| Net margin | -1602.1% | -1561.5% | -1456.7% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | -32.1 | -6.7 | -9.8 |
| Price to sales | 193.0 | — | 101.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 11-for-10 split · 2 Apr 2025
- 831-for-761 split · 11 Feb 2025
- 2-for-1 split · 19 Jan 2024
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.